Lung Cancer Clinical Trials in Dallas

Showing 341-360 of 564 trials

Evaluation of GLR2007 for Advanced Solid Tumors

NCT04444427

Evaluation of GLR2007 for Advanced Solid Tumors

Non-small Cell Lung CancerGlioblastoma Multiforme

Gan and Lee Pharmaceuticals, USA19 participantsStarted Jul 2020

Lafayette, Indiana, United States • Omaha, Nebraska, United States • Philadelphia, Pennsylvania, United States +1 more locations

TERMINATEDPhase 3< 1 mile

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

NCT00858364

This is a study in patients with chemotherapy induced anemia receiving multi-cycle chemotherapy for the treatment of stage IV non-small cell lung cancer (NSCLC). The primary objective of the study is to demonstrate that overall survival (OS) is not worse in participants on darbepoetin alfa treated to a hemoglobin ceiling of 12.0 g/dL compared to participants treated with placebo.

Non-Small Cell Lung CancerAnemiaCancer+1 more

Amgen2,549 participantsStarted Jul 2009

Anniston, Alabama, United States • Birmingham, Alabama, United States • Anchorage, Alaska, United States +563 more locations

Evaluation of GLR2007 for Advanced Solid Tumors

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Lung Cancer Trials in Other Cities

A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

A Study of LY3023414 in Participants With Advanced Cancer

PEN-866 in Patients With Advanced Solid Malignancies

A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors

Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

A Study of PLX2853 in Advanced Malignancies.

A Study of APG-1252 in Patients With SCLC or Other Solid Tumors

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)

Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC

First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

Safety Study of MGA271 in Refractory Cancer

A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)

Other Conditions in Dallas